West Chester, PA, United States of America

Anthony Sapienza

This inventor holds 3 USPTO granted patents. Top assignees: 3-Dimensional Pharmaceuticals, Inc., Smithkline Beecham Corporation, Other. Active years: 2001-2006.


% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Anthony Sapienza

Introduction

Anthony Sapienza is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on compounds that have the potential to impact medical treatments.

Latest Patents

One of his latest patents includes the development of pyrrolidine sulfonamides, which are compounds of Formula (I). These compounds are particularly noteworthy for their use as inhibitors of plasminogen activator inhibitor-1. This innovation could have important implications in the treatment of various medical conditions.

Career Highlights

Throughout his career, Anthony has worked with prominent companies such as SmithKline Beecham Corporation and 3-Dimensional Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Anthony has collaborated with several talented individuals, including Rameshkrishnan Viswanathan and Ingrid Christa Deckman. These partnerships have fostered a creative environment that has led to innovative solutions in their respective fields.

Conclusion

Anthony Sapienza's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…